Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04567381 · ClinicalTrials.gov registry record · NA

An Outcome Evaluation of the Project CHANGE-MS Violence Intervention Program

A NA study of Violence and Recidivism, sponsored by Medstar Health Research Institute.

Completed
Registry status
NA
Development phase
400
Enrollment target
1
Study location

NCT04567381 is a NA study of Violence and Recidivism that has completed, run by Medstar Health Research Institute. The registered enrollment target is 400 participants, below the 4,516-participant average among 19 other Violence trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04567381, a NA study of Violence and Recidivism, has completed, sponsored by Medstar Health Research Institute.

COMPLETED
Registry status
NA
Development phase
400 participants
Enrollment target
1
Study location

Study Summary

This is a prospective randomized control trial design to evaluate the effectiveness of a hospital based violence intervention program. Participants will be randomized into a "treatment as usual" group who will receive written referrals for services and an "enhanced services" group who will receive intensive case management over a one year period. Primary outcome will be rate of violent reinjury after enrollment. Follow-up will be for one year.

Conditions Studied

Interventions

  • OTHER Treatment as Usual
  • OTHER Enhanced Services

Study Locations (1)

District of Columbia

  • MedStar Washington Hospital Center - Washington D.C.

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2018-08-01
Est. Completion 2021-10-31
Phase NA

Sponsor

Medstar Health Research Institute

115 total trials

What the Registry Record Tells You About NCT04567381

The ClinicalTrials.gov registry entry for NCT04567381 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,516-participant average among 19 other Violence trials with a reported enrollment target (91% lower). The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Violence appearing as the primary indexed condition, and to 2 interventions - of which Treatment as Usual is the first listed.

NCT04567381 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.

Frequently Asked Questions

What is clinical trial NCT04567381 about?

NCT04567381 is a clinical study titled "An Outcome Evaluation of the Project CHANGE-MS Violence Intervention Program". This is a prospective randomized control trial design to evaluate the effectiveness of a hospital based violence intervention program. Participants will be randomized into a "treatment as usual" group who will receive written referrals for services and an "enhanced services" group who will receive i...

What is the current status of trial NCT04567381?

This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2018-08-01. Estimated completion is 2021-10-31.

What conditions does trial NCT04567381 study?

This clinical trial studies the following conditions: Violence, Recidivism.

What interventions are being tested in trial NCT04567381?

The interventions under investigation include: Treatment as Usual (OTHER), Enhanced Services (OTHER).

Who is sponsoring clinical trial NCT04567381?

This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04567381 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Violence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.